348 related articles for article (PubMed ID: 33827675)
1. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population.
Dong QY; Li TR; Jiang XY; Wang XN; Han Y; Jiang JH
Alzheimers Res Ther; 2021 Apr; 13(1):74. PubMed ID: 33827675
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
[TBL] [Abstract][Full Text] [Related]
3. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
Atay LO; Saka E; Akdemir UO; Yetim E; Balcı E; Arsava EM; Topcuoglu MA
Curr Alzheimer Res; 2023; 20(7):481-495. PubMed ID: 38050727
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
5. Exploring brain glucose metabolic patterns in cognitively normal adults at risk of Alzheimer's disease: A cross-validation study with Chinese and ADNI cohorts.
Li TR; Dong QY; Jiang XY; Kang GX; Li X; Xie YY; Jiang JH; Han Y;
Neuroimage Clin; 2022; 33():102900. PubMed ID: 34864286
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer's Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry.
Li K; Qu H; Ma M; Xia C; Cai M; Han F; Zhang Q; Gu X; Ma Q
Front Aging Neurosci; 2022; 14():816043. PubMed ID: 35547625
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
8. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
Silva-Rodríguez J; Labrador-Espinosa MA; Moscoso A; Schöll M; Mir P; Grothe MJ;
Brain; 2023 Nov; 146(11):4520-4531. PubMed ID: 37284793
[TBL] [Abstract][Full Text] [Related]
10. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis.
Li TR; Yao YX; Jiang XY; Dong QY; Yu XF; Wang T; Cai YN; Han Y
Alzheimers Res Ther; 2022 May; 14(1):66. PubMed ID: 35550625
[TBL] [Abstract][Full Text] [Related]
12. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
13. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
Baran TM; Lin FV;
J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
[TBL] [Abstract][Full Text] [Related]
14. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
17. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
[TBL] [Abstract][Full Text] [Related]
18. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
19. Functional Connectivity Between the Posterior Default Mode Network and Parahippocampal Gyrus Is Disrupted in Older Adults with Subjective Cognitive Decline and Correlates with Subjective Memory Ability.
Sharma N; Murari G; Vandermorris S; Verhoeff NPLG; Herrmann N; Chen JJ; Mah L
J Alzheimers Dis; 2021; 82(1):435-445. PubMed ID: 34024823
[TBL] [Abstract][Full Text] [Related]
20. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
